Exact Mass: 491.1612
Exact Mass Matches: 491.1612
Found 500 metabolites which its exact mass value is equals to given mass value 491.1612
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyanidin 3-(6'-acetyl-galactoside)
Cyanidin 3-(6-acetyl-galactoside) is found in highbush blueberry. Cyanidin 3-(6-acetyl-galactoside) is a constituent of the leaves of Nymphaea alba [CCD] Constituent of the leaves of Nymphaea alba [CCD]. Cyanidin 3-(6-acetyl-galactoside) is found in lowbush blueberry and highbush blueberry.
Cyanidin 3-(4-acetylglucoside)
Cyanidin 3-(4-acetylglucoside) is found in citrus. Cyanidin 3-(4-acetylglucoside) is isolated from oranges. Isolated from oranges. Cyanidin 3-(4-acetylglucoside) is found in sweet orange and citrus.
Birabresib
3,4-Dihydro-6-[[4-[[[3-(methylsulfonyl)phenyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]-2(1H)-quinolinone
3-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]-3-fluorophenyl}-1-(2-phenylacetyl)thiourea
Grapiprant
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C177182 - Prostaglandin Receptor Antagonist C274 - Antineoplastic Agent
Cyanidin 3-(6'-acetylglucoside)
Cyanidin 3-(6-acetylglucoside) is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Cyanidin 3-(6-acetylglucoside) is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cyanidin 3-(6-acetylglucoside) can be found in a number of food items such as highbush blueberry, chives, summer grape, and grape wine, which makes cyanidin 3-(6-acetylglucoside) a potential biomarker for the consumption of these food products.
Cyanidin 3-(6-acetylgalactoside)
Cyanidin 3-(4-acetylglucoside)
N-[(4-beta-L-rhamnopyranosyl)benzyl]-1-O-alpha-D-glucopyranosylthiocarboxamide
Asn Glu Thr Glu
Thr Gln Glu Asp
Ser Asp Arg Asp
Thr Glu Gln Asp
Ala Asp Thr Trp
Ala Asp Trp Thr
Ala Glu Ser Trp
Ala Glu Trp Ser
Ala Ser Glu Trp
Ala Ser Trp Glu
Ala Thr Asp Trp
Ala Thr Trp Asp
Ala Trp Asp Thr
Ala Trp Glu Ser
Ala Trp Ser Glu
Ala Trp Thr Asp
Cys Glu Ile Gln
Cys Glu Leu Gln
Cys Glu Gln Ile
Cys Glu Gln Leu
Cys Ile Glu Gln
Cys Ile Gln Glu
Cys Leu Glu Gln
Cys Leu Gln Glu
Cys Asn Gln Gln
Cys Pro Ser Trp
Cys Pro Trp Ser
Cys Gln Glu Ile
Cys Gln Glu Leu
Cys Gln Ile Glu
Cys Gln Leu Glu
Cys Gln Asn Gln
Cys Gln Gln Asn
Cys Ser Pro Trp
Cys Ser Trp Pro
Cys Trp Pro Ser
Cys Trp Ser Pro
Asp Ala Thr Trp
Asp Ala Trp Thr
Asp Asp Asp Lys
Asp Asp Asp Gln
Asp Asp Glu Asn
Asp Asp Gly Trp
Asp Asp Lys Asp
Asp Asp Asn Glu
Asp Asp Gln Asp
Asp Asp Arg Ser
Asp Asp Ser Arg
Asp Asp Trp Gly
Asp Glu Asp Asn
Asp Glu Asn Asp
Asp Glu Gln Thr
Asp Glu Thr Gln
Asp Phe Asn Pro
Asp Phe Pro Asn
Asp Gly Asp Trp
Asp Gly Trp Asp
Asp Ile Met Asn
Asp Ile Asn Met
Asp Lys Asp Asp
Asp Leu Met Asn
Asp Leu Asn Met
Asp Met Ile Asn
Asp Met Leu Asn
Asp Met Asn Ile
Asp Met Asn Leu
Asp Met Gln Val
Asp Met Val Gln
Asp Asn Asp Glu
Asp Asn Glu Asp
Asp Asn Phe Pro
Asp Asn Ile Met
Asp Asn Leu Met
Asp Asn Met Ile
Asp Asn Met Leu
Asp Asn Pro Phe
Asp Pro Phe Asn
Asp Pro Asn Phe
Asp Gln Asp Asp
Asp Gln Glu Thr
Asp Gln Met Val
Asp Gln Thr Glu
Asp Gln Val Met
Asp Arg Asp Ser
Asp Arg Ser Asp
Asp Ser Asp Arg
Asp Ser Arg Asp
Asp Thr Ala Trp
Asp Thr Glu Gln
Asp Thr Gln Glu
Asp Thr Trp Ala
Asp Val Met Gln
Asp Val Gln Met
Asp Trp Ala Thr
Asp Trp Asp Gly
Asp Trp Gly Asp
Asp Trp Thr Ala
Glu Ala Ser Trp
Glu Ala Trp Ser
Glu Cys Ile Gln
Glu Cys Leu Gln
Glu Cys Gln Ile
Glu Cys Gln Leu
Glu Asp Asp Asn
Glu Asp Asn Asp
Glu Asp Gln Thr
Glu Asp Thr Gln
Glu Glu Asn Thr
Glu Glu Gln Ser
Glu Glu Ser Gln
Glu Glu Thr Asn
Glu Gly Thr Trp
Glu Gly Trp Thr
Glu Ile Cys Gln
Glu Ile Gln Cys
Glu Leu Cys Gln
Glu Leu Gln Cys
Glu Met Asn Val
Glu Met Val Asn
Glu Asn Asp Asp
Glu Asn Glu Thr
Glu Asn Met Val
Glu Asn Thr Glu
Glu Asn Val Met
Glu Gln Cys Ile
Glu Gln Cys Leu
Glu Gln Asp Thr
Glu Gln Glu Ser
Glu Gln Ile Cys
Glu Gln Leu Cys
Glu Gln Ser Glu
Glu Gln Thr Asp
Glu Ser Ala Trp
Glu Ser Glu Gln
Glu Ser Gln Glu
Glu Ser Trp Ala
Glu Thr Asp Gln
Glu Thr Glu Asn
Glu Thr Gly Trp
Glu Thr Asn Glu
Glu Thr Gln Asp
Glu Thr Trp Gly
Glu Val Met Asn
Glu Val Asn Met
Glu Trp Ala Ser
Glu Trp Gly Thr
Glu Trp Ser Ala
Glu Trp Thr Gly
Phe Asp Asn Pro
Phe Asp Pro Asn
Phe Asn Asp Pro
Phe Asn Pro Asp
Phe Pro Asp Asn
Phe Pro Asn Asp
Gly Asp Asp Trp
Gly Asp Trp Asp
Gly Glu Thr Trp
Gly Glu Trp Thr
Gly Thr Glu Trp
Gly Thr Trp Glu
Gly Trp Asp Asp
Gly Trp Glu Thr
Gly Trp Thr Glu
Ile Cys Glu Gln
Ile Cys Gln Glu
Ile Asp Met Asn
Ile Asp Asn Met
Ile Glu Cys Gln
Ile Glu Gln Cys
Ile Met Asp Asn
Ile Met Asn Asp
Ile Asn Asp Met
Ile Asn Met Asp
Ile Gln Cys Glu
Ile Gln Glu Cys
Lys Asp Asp Asp
Leu Cys Glu Gln
Leu Cys Gln Glu
Leu Asp Met Asn
Leu Asp Asn Met
Leu Glu Cys Gln
Leu Glu Gln Cys
Leu Met Asp Asn
Leu Met Asn Asp
Leu Asn Asp Met
Leu Asn Met Asp
Leu Gln Cys Glu
Leu Gln Glu Cys
Met Asp Ile Asn
Met Asp Leu Asn
Met Asp Asn Ile
Met Asp Asn Leu
Met Asp Gln Val
Met Asp Val Gln
Met Glu Asn Val
Met Glu Val Asn
Met Ile Asp Asn
Met Ile Asn Asp
Met Leu Asp Asn
Met Leu Asn Asp
Met Met Asn Pro
Met Met Pro Asn
Met Asn Asp Ile
Met Asn Asp Leu
Met Asn Glu Val
Met Asn Ile Asp
Met Asn Leu Asp
Met Asn Met Pro
Met Asn Asn Asn
Met Asn Pro Met
Met Asn Val Glu
Met Pro Met Asn
Met Pro Asn Met
Met Gln Asp Val
Met Gln Val Asp
Met Val Asp Gln
Met Val Glu Asn
Met Val Asn Glu
Met Val Gln Asp
Asn Cys Gln Gln
Asn Asp Asp Glu
Asn Asp Glu Asp
Asn Asp Phe Pro
Asn Asp Ile Met
Asn Asp Leu Met
Asn Asp Met Ile
Asn Asp Met Leu
Asn Asp Pro Phe
Asn Glu Asp Asp
Asn Glu Glu Thr
Asn Glu Met Val
Asn Glu Val Met
Asn Phe Asp Pro
Asn Phe Pro Asp
Asn Ile Asp Met
Asn Ile Met Asp
Asn Leu Asp Met
Asn Leu Met Asp
Asn Met Asp Ile
Asn Met Asp Leu
Asn Met Glu Val
Asn Met Ile Asp
Asn Met Leu Asp
Asn Met Met Pro
Asn Met Asn Asn
Asn Met Pro Met
Asn Met Val Glu
Asn Asn Met Asn
Asn Asn Asn Met
Asn Pro Asp Phe
Asn Pro Phe Asp
Asn Pro Met Met
Asn Gln Cys Gln
Asn Gln Gln Cys
Asn Thr Glu Glu
Asn Val Glu Met
Asn Val Met Glu
Pro Cys Ser Trp
Pro Cys Trp Ser
Pro Asp Phe Asn
Pro Asp Asn Phe
Pro Phe Asp Asn
Pro Phe Asn Asp
Pro Met Met Asn
Pro Met Asn Met
Pro Asn Asp Phe
Pro Asn Phe Asp
Pro Asn Met Met
Pro Ser Cys Trp
Pro Ser Trp Cys
Pro Trp Cys Ser
Pro Trp Ser Cys
Gln Cys Glu Ile
Gln Cys Glu Leu
Gln Cys Ile Glu
Gln Cys Leu Glu
Gln Cys Asn Gln
Gln Cys Gln Asn
Gln Asp Asp Asp
Gln Asp Glu Thr
Gln Asp Met Val
Gln Asp Thr Glu
Gln Glu Asp Thr
Gln Glu Glu Ser
Gln Glu Ser Glu
Gln Glu Thr Asp
Gln Asn Cys Gln
Gln Asn Gln Cys
Gln Gln Cys Asn
Gln Gln Asn Cys
Gln Ser Glu Glu
Gln Thr Asp Glu
Gln Thr Glu Asp
Arg Asp Asp Ser
Arg Asp Ser Asp
Arg Ser Asp Asp
Ser Ala Glu Trp
Ser Ala Trp Glu
Ser Cys Pro Trp
Ser Cys Trp Pro
Ser Asp Asp Arg
Ser Glu Ala Trp
Ser Glu Glu Gln
Ser Glu Gln Glu
Ser Glu Trp Ala
Ser Pro Cys Trp
Ser Pro Trp Cys
Ser Gln Glu Glu
Ser Arg Asp Asp
Ser Trp Ala Glu
Ser Trp Cys Pro
Ser Trp Glu Ala
Ser Trp Pro Cys
Thr Ala Asp Trp
Thr Ala Trp Asp
Thr Asp Ala Trp
Thr Asp Glu Gln
Thr Asp Gln Glu
Thr Asp Trp Ala
Thr Glu Asp Gln
Thr Glu Glu Asn
Thr Glu Gly Trp
Thr Glu Asn Glu
Thr Glu Trp Gly
Thr Gly Glu Trp
Thr Gly Trp Glu
Thr Asn Glu Glu
Thr Gln Asp Glu
Thr Trp Ala Asp
Thr Trp Asp Ala
Thr Trp Glu Gly
Thr Trp Gly Glu
Trp Ala Asp Thr
Trp Ala Glu Ser
Trp Ala Ser Glu
Trp Ala Thr Asp
Trp Cys Pro Ser
Trp Cys Ser Pro
Trp Asp Ala Thr
Trp Asp Asp Gly
Trp Asp Gly Asp
Trp Asp Thr Ala
Trp Glu Ala Ser
Trp Glu Gly Thr
Trp Glu Ser Ala
Trp Glu Thr Gly
Trp Gly Asp Asp
Trp Gly Glu Thr
Trp Gly Thr Glu
Trp Pro Cys Ser
Trp Pro Ser Cys
Trp Ser Ala Glu
Trp Ser Cys Pro
Trp Ser Glu Ala
Trp Ser Pro Cys
Trp Thr Ala Asp
Trp Thr Asp Ala
Trp Thr Glu Gly
Trp Thr Gly Glu
4-[[5-(acetylamino)-1H-indol-3-yl]methyl]-3-methoxy-N-[(2-methylphenyl)sulfonyl]-Benzamide
(2R,3R)-2,3-dihydroxybutanedioic acid,(2S,3S)-3,4-dimethyl-2-phenylmorpholine
Bucladesine sodium
C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides > C01CE - Phosphodiesterase inhibitors Bucladesine sodium salt (Dibutyryl-cAMP sodium salt) is a stabilized cyclic AMP (cAMP) analog and a selective PKA activator. Bucladesine sodium salt raises the intracellular levels of cAMP. Bucladesine sodium salt is also a phosphodiesterase (PDE) inhibitor. Bucladesine sodium salt has anti-inflammatory activity and can be used for impaired wound healing[1][2][3][4].
Birabresib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor
4,7,8,9-tetra-o-acetyl-n-acetylneuraminic acid methyl ester
(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) isopropyl Methyl dicarbonate
Vestipitant
D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
Grapiprant
C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C177182 - Prostaglandin Receptor Antagonist C274 - Antineoplastic Agent
Flunixin Meglumine
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D058633 - Antipyretics
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide
N-(1-dibutoxyphosphoryl-4-oxo-1-naphthalenyl)benzenesulfonamide
3-Amino-2-[(4-methoxyanilino)-oxomethyl]-4-(4-methoxyphenyl)-6-methyl-5-thieno[2,3-b]pyridinecarboxylic acid ethyl ester
N-[2-(3-methoxyphenyl)-4-[(4-methoxyphenyl)methoxy]-6-quinolinyl]-3-pyridinecarboxamide
2-[[2-[[4-(2-Methoxyethyl)-5-(4-methoxyphenyl)-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester
Methyl 4-[1-[2-(3,4-dimethoxyphenyl)ethyl]-3-(4-methoxyphenoxy)-4-oxoazetidin-2-yl]benzoate
4-Morpholinyl-[4-[3-[4-(4-morpholinylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl]-1-piperidinyl]methanone
2-[3-(1-Benzotriazolylmethyl)-4-methoxyphenyl]-3-(4-methoxyphenyl)-1,2-dihydroquinazolin-4-one
N-[3-[4-(4-fluorophenyl)-1-piperazinyl]-1,4-dioxo-2-naphthalenyl]benzenesulfonamide
6-amino-5-cyano-2-[[(3-cyano-6-methyl-7,8-dihydro-5H-1,6-naphthyridin-2-yl)thio]methyl]-4-(4-fluorophenyl)-4H-pyran-3-carboxylic acid methyl ester
6-(Methylamino)hexane-1,2,3,4,5-pentol 2-[2-methyl-3-(trifluoromethyl)anilino]-3-pyridinecarboxylic acid
2-[[2-(Cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-[1-oxo-2-[[oxo(thiophen-2-yl)methyl]amino]ethyl]amino]acetic acid ethyl ester
(3R)-3-(2-hydroxyethyl)-2-N-propan-2-yl-4-[3-[(E)-prop-1-enyl]phenyl]-6-N-(1,3-thiazol-2-yl)-1,3-dihydropyrrolo[3,4-c]pyridine-2,6-dicarboxamide
N-[(1R,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
2-fluoro-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-fluoro-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-fluoro-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-fluoro-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
4-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
4-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
N-[(1R,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
4-fluoro-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-fluoro-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-fluoro-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-fluoro-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-fluoro-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
4-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
4-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
4-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
4-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
4-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzenesulfonamide
N-[(1S,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1R,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
N-[(1S,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
4-[4-[(1S,5R)-3-(3-methoxyphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
(2R,3R,3aS,9bS)-N-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-1-methylsulfonyl-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-N-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-1-methylsulfonyl-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,4S,5R)-6-[3-[(4-aminophenyl)sulfonylamino]-2-phenylpyrazol-1-ium-1-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
PF-573228
cyanidin 3-O-(6-O-acetyl-beta-D-glucoside)
An anthocyanin cation consisting of cyanidin having a 6-O-acetyl-beta-D-glucosyl residue attached at the 3-hydroxy position.
FSI-TN42
ALDH1A1/2-IN-1 is an ALDH1A1 and ALDH1A2 inhibitor that can be used for preventing spermatogenesis[1].
IGUANA-1
IGUANA-1 is a potent inhibitor of ALDH1B1, which is a mitochondrial enzyme that promotes colorectal and pancreatic cancer. IGUANA-1 has significant inhibition against cancer cells[1].